| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| RPL18P11 |
|
ribosomal protein L18 pseudogene 11
|
|
|
0.931 |
0.077 |
| FOXP4-AS1 |
|
FOXP4 antisense RNA 1
|
|
|
0.736 |
0.154 |
| LINC01414 |
|
long intergenic non-protein coding RNA 1414
|
|
|
1.000 |
0.038 |
| HYKK |
A2RU49
|
hydroxylysine kinase
|
|
7.3E-06 |
0.769 |
0.346 |
| MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
| LDB2 |
O43679
|
LIM domain binding 2
|
Transcription factor
|
0.95 |
0.760 |
0.115 |
| FAM13A |
O94988
|
family with sequence similarity 13 member A
|
|
1.9E-18 |
0.653 |
0.462 |
| APOM |
O95445
|
apolipoprotein M
|
|
9.6E-04 |
0.590 |
0.769 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| HLA-DQA2 |
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
1.0E-05 |
0.617 |
0.769 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
| CHRNA5 |
P30532
|
cholinergic receptor nicotinic alpha 5 subunit
|
Ion channel
|
2.1E-06 |
0.593 |
0.577 |
| CHRNB4 |
P30926
|
cholinergic receptor nicotinic beta 4 subunit
|
Ion channel
|
0.14 |
0.644 |
0.423 |
| CHRNA3 |
P32297
|
cholinergic receptor nicotinic alpha 3 subunit
|
Ion channel
|
1.4E-07 |
0.588 |
0.692 |